HPV vaccine in Rwanda: Different disease, same double standard

The Lancet

Volumn 378, Issue 9807, 2011, Pages 1916-

  Binagwaho, Agnes ^a,b   Wagner, Claire M ^b   Nutt, Cameron T ^c  

^a Ministry of Health of Rwanda   (Rwanda)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

DRUG COST; HEALTH PROGRAM; HUMAN; IMMUNIZATION; LETTER; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RWANDA; UTERINE CERVIX CANCER;

EID: 82755164341     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61837-0     Document Type: Letter

References (5)

1. N Ouedraogo, O Müller, A Jahn, A Gerhardus Human papillomavirus vaccination in Africa Lancet 377 2011 315 316
2. Ministry of Health of Rwanda Demographic and health survey 2010: preliminary report 2011 National Institute of Statistics of Rwanda Kigali
3. M Schiffman, S Wacholder Success of HPV vaccination is now a matter of coverage Lancet Oncol 2011 10.1016/S1470-2045(11)70324-2 published online Nov 9.
4. Merck Merck offers further commitment to sustainable vaccine access http://www.merck.com/newsroom/news-release-archive/corporate-responsibility/ 2011-0605.html (accessed Aug 9, 2011).
5. GAVI Alliance Board members http://www.gavialliance.org/about/governance/ gavi-board/members/ (accessed Aug 9, 2011).